| Dr Glenn Francis Ragalie, MD | |
|
1155 N Honey Creek Pkwy, Wauwatosa, WI 53213-3189 | |
| (414) 615-5936 | |
| (414) 615-5927 |
| Full Name | Dr Glenn Francis Ragalie |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1155 N Honey Creek Pkwy, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740382555 | NPI | - | NPPES |
| 30330900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 21819 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn Francis Ragalie, MD 1621 Church St, Wauwatosa, WI 53213-2541 Ph: (414) 258-7498 | Dr Glenn Francis Ragalie, MD 1155 N Honey Creek Pkwy, Wauwatosa, WI 53213-3189 Ph: (414) 615-5936 |
News Archive
Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneration (AMD).
Researchers have found that microRNAs can be useful prognostic biomarkers for individuals with urothelial carcinoma.
MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in, and is a contributor to, the nationally-sponsored Direct Project under the Office of the National Coordinator of Health IT.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
› Verified 2 days ago
Geetha Ganesan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-607-6336 | |
Haroon Zubair, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-607-6336 | |
David A. Carron, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1033 N Mayfair Rd, Suite 101, Wauwatosa, WI 53226 Phone: 414-454-0600 Fax: 414-454-0971 | |
Dr. Kavita Sharma, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1155 N Honey Creek Pkwy, Wauwatosa, WI 53213 Phone: 414-615-5900 Fax: 414-615-5927 | |
Robert Michael Molloy, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1033 N Mayfair Rd, Suite 101, Wauwatosa, WI 53226 Phone: 414-454-0600 Fax: 414-454-0971 | |
Ankur N Patel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-607-6336 | |
Dr. James T Kwiatt, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1033 N Mayfair Rd, Suite 101, Wauwatosa, WI 53226 Phone: 414-454-0500 Fax: 414-454-0971 |